Filing Details

Accession Number:
0001144204-10-008405
Form Type:
5
Zero Holdings:
No
Publication Time:
2010-02-16 12:00:00
Reporting Period:
2009-12-31
Filing Date:
2010-02-16
Accepted Time:
2010-02-16 17:29:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1137883 Brainstorm Cell Therapeutics Inc BCLI Biological Products, (No Disgnostic Substances) (2836) 912061050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1303782 C Jonathan Javitt C/O Brainstorm Cell Therapeutics Inc.,
110 East 59Th Street
New York, NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2008-08-03 960,000 $275,000.00 960,000 No 4 P Direct
Common Stock Disposition 2009-09-29 213,988 $0.34 746,012 No 4 S Direct
Common Stock Disposition 2009-09-30 50,000 $0.32 696,012 No 4 S Direct
Common Stock Disposition 2009-10-01 2,800 $0.34 693,212 No 4 S Direct
Common Stock Disposition 2009-10-02 5,224 $0.34 687,988 No 4 S Direct
Common Stock Disposition 2009-10-05 87,509 $0.34 600,479 No 4 S Direct
Common Stock Disposition 2009-10-06 48,869 $0.34 551,610 No 4 S Direct
Common Stock Disposition 2009-10-14 60,000 $0.32 491,610 No 4 S Direct
Common Stock Disposition 2009-10-22 31,610 $0.32 460,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Mr. Javitt acquired these shares of common stock of Brainstorm Cell Therapeutics Inc. from ACCBT Corp. on August 3, 2008.